Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Entrada Therapeutics, Inc. (TRDA)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
15 Feb 2024
Doshi Dipal
CEO, Director, Officer
Entrada Therapeutics, Inc.
(TRDA)
243,279
-0%
1,000
$15.00
$15,000.00
SELL
16 Jan 2024
Doshi Dipal
CEO, Director, Officer
Entrada Therapeutics, Inc.
(TRDA)
244,279
-0%
1,000
$15.99
$15,990.00
SELL
21 Dec 2023
WENTWORTH KORY JAMES
Chief Financial Officer, Officer
Entrada Therapeutics, Inc.
(TRDA)
49,571
-20%
12,500
$15.59
$194,845.27
SELL
20 Dec 2023
Doshi Dipal
President and CEO, Director, Officer
Entrada Therapeutics, Inc.
(TRDA)
245,279
-0%
1,000
$15.00
$15,000.00
SELL
13 Nov 2023
Doshi Dipal
President and CEO, Director, Officer
Entrada Therapeutics, Inc.
(TRDA)
246,279
-0%
1,000
$16.23
$16,230.00
SELL
13 Sep 2023
Doshi Dipal
President and CEO, Director, Officer
Entrada Therapeutics, Inc.
(TRDA)
248,279
-0%
1,000
$15.00
$15,000.00
SELL
1 Sep 2023
Dowden Nathan J
Chief Operating Officer, Officer
Entrada Therapeutics, Inc.
(TRDA)
48,227
-1%
972
$13.47
$13,089.09
SELL
1 Sep 2023
KREHER NERISSA
Chief Medical Officer, Officer
Entrada Therapeutics, Inc.
(TRDA)
40,058
-2%
892
$13.48
$12,021.75
SELL
1 Sep 2023
WENTWORTH KORY JAMES
Chief Financial Officer, Officer
Entrada Therapeutics, Inc.
(TRDA)
49,617
-1%
950
$13.48
$12,806.17
SELL
14 Aug 2023
Doshi Dipal
President and CEO, Director, Officer
Entrada Therapeutics, Inc.
(TRDA)
201,069
-0%
1,000
$15.67
$15,671.30
SELL
2 Aug 2023
KREHER NERISSA
Chief Medical Officer, Officer
Entrada Therapeutics, Inc.
(TRDA)
27,130
-49%
26,710
$14.76
$394,219.20
SELL
10 Jul 2023
Dowden Nathan J
Chief Operating Officer, Officer
Entrada Therapeutics, Inc.
(TRDA)
35,376
-16%
7,097
$18.03
$127,938.17
SELL
10 Jul 2023
Sethuraman Natarajan
Chief Scientific Officer, Officer
Entrada Therapeutics, Inc.
(TRDA)
153,447
-10%
17,878
$18.03
$322,389.28
SELL
10 Jul 2023
WENTWORTH KORY JAMES
Chief Financial Officer, Officer
Entrada Therapeutics, Inc.
(TRDA)
36,747
-21%
10,000
$17.99
$179,862.19
SELL
21 Jun 2023
WENTWORTH KORY JAMES
Chief Financial Officer, Officer
Entrada Therapeutics, Inc.
(TRDA)
36,864
-32%
17,500
$15.01
$262,648.25
SELL
20 Jun 2023
Dowden Nathan J
Chief Operating Officer, Officer
Entrada Therapeutics, Inc.
(TRDA)
42,473
-27%
15,982
$15.42
$246,403.31
SELL
27 Apr 2023
Doshi Dipal
President and CEO, Director, Officer
Entrada Therapeutics, Inc.
(TRDA)
202,069
-0%
2,000
$13.71
$27,421.80
SELL
17 Apr 2023
Doshi Dipal
President and CEO, Director, Officer
Entrada Therapeutics, Inc.
(TRDA)
204,069
-1%
2,092
$18.01
$37,675.25
SELL
17 Apr 2023
Sethuraman Natarajan
Chief Scientific Officer, Officer
Entrada Therapeutics, Inc.
(TRDA)
171,325
-2%
3,961
$18.00
$71,315.82
SELL
27 Mar 2023
Doshi Dipal
President and CEO, Director, Officer
Entrada Therapeutics, Inc.
(TRDA)
256,011
-0%
2,000
$14.72
$29,435.28
SELL
1 Mar 2023
KREHER NERISSA
Chief Medical Officer, Officer
Entrada Therapeutics, Inc.
(TRDA)
41,494
-3%
1,641
$10.56
$17,336.03
SELL
1 Mar 2023
WENTWORTH KORY JAMES
Chief Financial Officer, Officer
Entrada Therapeutics, Inc.
(TRDA)
42,302
-3%
1,747
$10.53
$18,389.01
SELL
28 Feb 2023
Doshi Dipal
President and CEO, Director, Officer
Entrada Therapeutics, Inc.
(TRDA)
161,835
-1%
2,000
$12.00
$24,000.00
SELL
27 Jan 2023
Doshi Dipal
President and CEO, Director, Officer
Entrada Therapeutics, Inc.
(TRDA)
163,835
-1%
2,000
$12.00
$24,001.00
SELL
9 Jan 2023
Doshi Dipal
President and CEO, Director, Officer
Entrada Therapeutics, Inc.
(TRDA)
165,835
-1%
2,410
$15.02
$36,195.55
SELL
30 Dec 2022
KREHER NERISSA
Chief Medical Officer, Officer
Entrada Therapeutics, Inc.
(TRDA)
15,516
-25%
5,200
$13.45
$69,931.68
SELL
27 Dec 2022
Doshi Dipal
President and CEO, Director, Officer
Entrada Therapeutics, Inc.
(TRDA)
168,245
-7%
14,590
$15.02
$219,119.34
SELL
8 Dec 2022
WENTWORTH KORY JAMES
Chief Financial Officer, Officer
Entrada Therapeutics, Inc.
(TRDA)
16,509
-21%
4,550
$18.95
$86,237.97
SELL
2 Dec 2022
WENTWORTH KORY JAMES
Chief Financial Officer, Officer
Entrada Therapeutics, Inc.
(TRDA)
16,509
-15%
3,110
$18.19
$56,559.48
SELL
16 Nov 2022
WENTWORTH KORY JAMES
Chief Financial Officer, Officer
Entrada Therapeutics, Inc.
(TRDA)
16,509
-1%
200
$18.10
$3,620.00
SELL
31 Oct 2022
Dowden Nathan J
Chief Operating Officer, Officer
Entrada Therapeutics, Inc.
(TRDA)
45,283
-4%
2,100
$24.05
$50,495.13
SELL
25 Oct 2022
Doshi Dipal
President and CEO, Director, Officer
Entrada Therapeutics, Inc.
(TRDA)
184,835
-7%
14,061
$20.80
$292,511.60
SELL
25 Oct 2022
KREHER NERISSA
Chief Medical Officer, Officer
Entrada Therapeutics, Inc.
(TRDA)
25,033
-34%
13,000
$21.27
$276,548.70
SELL
25 Oct 2022
Dowden Nathan J
Chief Operating Officer, Officer
Entrada Therapeutics, Inc.
(TRDA)
53,697
-14%
9,348
$20.77
$194,191.03
SELL
20 Oct 2022
Doshi Dipal
President and CEO, Director, Officer
Entrada Therapeutics, Inc.
(TRDA)
200,137
-2%
5,939
$18.64
$110,712.80
SELL
20 Oct 2022
Dowden Nathan J
Chief Operating Officer, Officer
Entrada Therapeutics, Inc.
(TRDA)
58,033
-9%
6,080
$18.66
$113,426.11
SELL
26 Sep 2022
Doshi Dipal
President and CEO, Director, Officer
Entrada Therapeutics, Inc.
(TRDA)
204,835
-4%
10,587
$15.25
$161,441.70
SELL
26 Sep 2022
KREHER NERISSA
Chief Medical Officer, Officer
Entrada Therapeutics, Inc.
(TRDA)
20,716
-29%
8,593
$15.29
$131,428.16
SELL
26 Sep 2022
Dowden Nathan J
Chief Operating Officer, Officer
Entrada Therapeutics, Inc.
(TRDA)
63,026
-2%
1,544
$15.45
$23,853.54
SELL
21 Sep 2022
KREHER NERISSA
Chief Medical Officer, Officer
Entrada Therapeutics, Inc.
(TRDA)
20,716
-17%
4,280
$15.08
$64,560.09
SELL
21 Sep 2022
Dowden Nathan J
Chief Operating Officer, Officer
Entrada Therapeutics, Inc.
(TRDA)
64,355
-6%
4,293
$15.11
$64,877.65
SELL
21 Sep 2022
Doshi Dipal
President and CEO, Director, Officer
Entrada Therapeutics, Inc.
(TRDA)
215,422
-2%
4,425
$15.10
$66,837.83
SELL
15 Sep 2022
Doshi Dipal
President and CEO, Director, Officer
Entrada Therapeutics, Inc.
(TRDA)
219,847
-0%
200
$15.04
$3,008.00
SELL
15 Sep 2022
Dowden Nathan J
Chief Operating Officer, Officer
Entrada Therapeutics, Inc.
(TRDA)
68,648
-0%
100
$15.01
$1,501.00
SELL
15 Sep 2022
KREHER NERISSA
Chief Medical Officer, Officer
Entrada Therapeutics, Inc.
(TRDA)
20,716
-0%
106
$15.01
$1,591.42
SELL
8 Sep 2022
KREHER NERISSA
Chief Medical Officer, Officer
Entrada Therapeutics, Inc.
(TRDA)
20,716
-8%
2,021
$15.11
$30,531.28
SELL
8 Sep 2022
Dowden Nathan J
Chief Operating Officer, Officer
Entrada Therapeutics, Inc.
(TRDA)
68,748
-2%
1,777
$15.11
$26,845.13
SELL
29 Aug 2022
Doshi Dipal
President and CEO, Director, Officer
Entrada Therapeutics, Inc.
(TRDA)
206,710
-0%
2,000
$12.72
$25,435.10
SELL
24 Aug 2022
WENTWORTH KORY JAMES
Chief Financial Officer, Officer
Entrada Therapeutics, Inc.
(TRDA)
10,986
-29%
4,669
$13.78
$64,361.54
SELL
19 Aug 2022
WENTWORTH KORY JAMES
Chief Financial Officer, Officer
Entrada Therapeutics, Inc.
(TRDA)
14,538
-44%
11,655
$13.08
$152,432.03
SELL
16 Aug 2022
WENTWORTH KORY JAMES
Chief Financial Officer, Officer
Entrada Therapeutics, Inc.
(TRDA)
20,221
-2%
600
$13.02
$7,814.00
SELL
27 Jul 2022
Doshi Dipal
President and CEO, Director, Officer
Entrada Therapeutics, Inc.
(TRDA)
208,710
-0%
2,000
$12.00
$24,000.00
SELL
27 Jun 2022
Dowden Nathan J
Chief Operating Officer, Officer
Entrada Therapeutics, Inc.
(TRDA)
64,893
-10%
7,714
$13.00
$100,282.00
SELL
27 Jun 2022
Doshi Dipal
President and CEO, Director, Officer
Entrada Therapeutics, Inc.
(TRDA)
210,710
-1%
4,000
$12.00
$48,000.00
BUY
2 Jun 2022
BAKER BROS. ADVISORS LP
10% Owner
Entrada Therapeutics, Inc.
(TRDA)
361,043
+12%
40,947
$6.37
$260,759.64
BUY
20 May 2022
BAKER BROS. ADVISORS LP
10% Owner
Entrada Therapeutics, Inc.
(TRDA)
357,509
+15%
48,509
$5.82
$282,447.22
BUY
16 May 2022
BAKER BROS. ADVISORS LP
10% Owner
Entrada Therapeutics, Inc.
(TRDA)
351,020
+25%
71,944
$5.99
$430,700.75
BUY
12 Jan 2022
Crowley John F
Director
Entrada Therapeutics, Inc.
(TRDA)
5,000
+100%
5,000
$9.72
$48,575.00
BUY
2 Nov 2021
MPM BioVentures 2014, L.P.
10% Owner
Entrada Therapeutics, Inc.
(TRDA)
4,425,784
+2%
100,000
$20.00
$2,000,000.00
BUY
2 Nov 2021
PARMAR KUSH
Director, 10% Owner
Entrada Therapeutics, Inc.
(TRDA)
1,132,357
+28%
250,000
$20.00
$5,000,000.00
BUY
2 Nov 2021
MPM BIOVENTURES 2018, L.P.
10% Owner
Entrada Therapeutics, Inc.
(TRDA)
4,425,784
+2%
100,000
$20.00
$2,000,000.00
BUY
2 Nov 2021
Redmile Group, LLC
10% Owner
Entrada Therapeutics, Inc.
(TRDA)
1,954,420
+104%
1,000,000
$20.00
$20,000,000.00
BUY
2 Nov 2021
5AM Ventures V, L.P.
10% Owner
Entrada Therapeutics, Inc.
(TRDA)
1,132,357
+28%
250,000
$20.00
$5,000,000.00
BUY
2 Nov 2021
Foley Todd
Director, 10% Owner
Entrada Therapeutics, Inc.
(TRDA)
4,425,784
+2%
100,000
$20.00
$2,000,000.00
Home